JP2023534959A5 - - Google Patents
Info
- Publication number
- JP2023534959A5 JP2023534959A5 JP2023502897A JP2023502897A JP2023534959A5 JP 2023534959 A5 JP2023534959 A5 JP 2023534959A5 JP 2023502897 A JP2023502897 A JP 2023502897A JP 2023502897 A JP2023502897 A JP 2023502897A JP 2023534959 A5 JP2023534959 A5 JP 2023534959A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052599P | 2020-07-16 | 2020-07-16 | |
| US63/052,599 | 2020-07-16 | ||
| PCT/US2021/070881 WO2022016190A1 (en) | 2020-07-16 | 2021-07-15 | Antibodies against the muc1-c/extracellular domain (muc1-c/ecd) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534959A JP2023534959A (ja) | 2023-08-15 |
| JPWO2022016190A5 JPWO2022016190A5 (https=) | 2024-06-07 |
| JP2023534959A5 true JP2023534959A5 (https=) | 2024-06-07 |
Family
ID=79554266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502897A Pending JP2023534959A (ja) | 2020-07-16 | 2021-07-15 | Ｍｕｃ１－ｃ／細胞外ドメイン（ｍｕｃ１－ｃ／ｅｃｄ）に対する抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230265208A1 (https=) |
| EP (1) | EP4182354A4 (https=) |
| JP (1) | JP2023534959A (https=) |
| KR (1) | KR20230116767A (https=) |
| CN (1) | CN117693530A (https=) |
| AU (1) | AU2021310499A1 (https=) |
| BR (1) | BR112023000728A2 (https=) |
| CA (1) | CA3186181A1 (https=) |
| IL (1) | IL299903A (https=) |
| MX (1) | MX2023000784A (https=) |
| WO (1) | WO2022016190A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250156802A (ko) * | 2023-03-03 | 2025-11-03 | 비원 메디슨즈 아이 게엠베하 | Muc1 및 cd16a 항체 및 사용 방법 |
| EP4676976A1 (en) * | 2023-03-03 | 2026-01-14 | Beone Medicines I GmbH | Muc1 antibodies and methods of use |
| WO2025217515A2 (en) | 2024-04-12 | 2025-10-16 | Dana-Farber Cancer Institute, Inc. | Identification of muc1-c as a target for the treatment of squamous cell carcinomas |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2287195B1 (en) * | 2004-07-01 | 2019-05-15 | Novo Nordisk A/S | Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| US20170204191A1 (en) * | 2008-10-06 | 2017-07-20 | Cynthia C. Bamdad | Muc1* antibodies |
| US10059775B2 (en) * | 2014-01-29 | 2018-08-28 | Dana-Farber Cancer Institute, Inc. | Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) |
| US10617773B2 (en) * | 2016-08-05 | 2020-04-14 | Dana-Farber Cancer Institute, Inc. | Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) |
-
2021
- 2021-07-15 US US18/005,562 patent/US20230265208A1/en active Pending
- 2021-07-15 WO PCT/US2021/070881 patent/WO2022016190A1/en not_active Ceased
- 2021-07-15 CA CA3186181A patent/CA3186181A1/en active Pending
- 2021-07-15 CN CN202180063154.3A patent/CN117693530A/zh active Pending
- 2021-07-15 BR BR112023000728A patent/BR112023000728A2/pt unknown
- 2021-07-15 JP JP2023502897A patent/JP2023534959A/ja active Pending
- 2021-07-15 IL IL299903A patent/IL299903A/en unknown
- 2021-07-15 MX MX2023000784A patent/MX2023000784A/es unknown
- 2021-07-15 AU AU2021310499A patent/AU2021310499A1/en active Pending
- 2021-07-15 EP EP21842547.8A patent/EP4182354A4/en active Pending
- 2021-07-15 KR KR1020237005383A patent/KR20230116767A/ko active Pending